Engaging Thought Leadership
Over 75 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
Discovery US 2024
07 - 08 November 2024 | Boston, MA
Connecting experts in biology & chemistry to advance small molecule drug discovery
Discovery US 2024
Meet Our Expert Speakers
Discovery US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Below are some of our featured speakers:
Abhijat Vatsyayan
Head of Artificial Intelligence,
Taiho Oncology
Divya Kanichar
Director,
Insitro
Fiona Mack
Vice President,
Bayer
Giovanni Piedimonte
Vice President of Research,
Tulane University
Hong Cheng
Vice President, Head of Research Strategy,
Sanofi
Jason Ekert
Head of US Translational Technology,
UCB
Jennifer Busby
Director Biology,
Exscientia
Julie Owen
Director,
Recursion Pharmaceuticals
Lihua Yu
Chief Data Officer,
LifeMine Therapeutics
Martin Redhead
Associate Vice President,
Exscientia
Paul Scola
Senior Director, Chemistry,
Bristol Myers Squibb
Shelley Allen
Vice President, Head of Drug Discovery,
Nimble Therapeutics
Aaron Van Hooser
Senior Director, Computational Biology,
Sensorium Therapeutics
Anneke den Hollander
Head of Cellular Genomics, Genome Biology and Functional Genomics,
AbbVie
Ari Allyn-Feuer
Director of Artificial Intelligence Product,
GSK
Boguslaw Nocek
Senior Director,
Eli Lilly
Christopher Hickey
Associate Director,
Arvinas
Dima Kozakov
Professor,
The Laufer Center
Dr. Hemachandran Kannan
Director of the AI Research Centre,
Woxsen University
Elizabeth D'Ambrosio
Investigator, ELT,
GSK
Finith Jernigan
Head of Early Discovery,
Psivant
Graham Dempsey
Founder & Chief Scientific Officer,
Quiver Bioscience
Gvido Cebers
Global Head of Drug Safety, Research & Evaluation,
Takeda Pharmaceuticals
Ilkay Us
Director, High Throughput Screening,
Cornell University
Ivan Cornella
CSO,
Covant Therapeutics
James Hickman
Professor of NanoScience Technology,
University of Central Florida
Jody Logan
Senior Director of Tech Transfer,
Genentech
Joe Franklin
Senior Vice President and Head of Early Discovery,
Anagenex
Jonathan Solomon
Director,
Novartis Pharma
Joseph Wu
Director, Stanford Cardiovascular Institute; Co-Founder, Greenstone Biosciences,
Stanford University
Judith Ronau
Senior Scientist,
AbbVie
Julia Fox
Director, Data & Analytics,
Takeda
Kian Tan
Director,
Novartis
Lena Dolgikh
Head of CADD,
Monte Rosa Therapeutics
Melissa Ford
Associate Director,
Kymera Therapeutics
Michael Brehm
Associate Professor & Associate Director, Diabetes Center of Excellence,
University of Massachusetts Medical School
Nicholas Larsen
Senior Director of Biophysics and Structural Biology,
Kestrel Therapeutics
Noa Liberman-Isakov
Senior Scientist,
Sarepta Therapeutics
Noel Powell
Senior Director -Medicinal Chemistry,
Recursion Pharmaceuticals
Prashant Gahtori
Professor,
Graphic Era Hill University
Rick Ewing
Vice President, Head of Chemistry,
Rapafusyn Pharmaceuticals
.jpg?length=600&name=cea85013-12ce-4af4-93af-4632eadcf4de-2-11764368speaker_photo-IMG_8722-(3).jpg)
Robert Fremeau
Founder & CSO,
BrainStorm Therapeutics
Ron Weiss
Professor,
Massachusetts Institute of Technology
Sarah Wilson
Principal Research Scientist,
AbbVie
Tudor Oprea
CEO,
Expert Systems
Yuan Wang
Head, Research Analytics,
UCB
Yunhui Ge
Scientist,
Alkermes
Meet Our Esteemed Sponsors
Gold Sponsors
Optibrium
Gold Sponsor
Optibrium develops exceptional software and AI solutions that help scientists advance their discovery projects. Cutting-edge science, backed up by rigorous research, underpins their intuitive software for compound design, optimisation and data analysis. Optibrium’s comprehensive in silico platform improves the speed, efficiency, and productivity of the discovery process and supports a worldwide customer base, including leading pharma, biotech, agrochemical and flavouring companies and not-for-profit and academic groups. Optibrium was founded in 2009 and is headquartered in Cambridge, UK, with a US subsidiary, Optibrium Inc., based in Cambridge MA. For further information, visit www.optibrium.com.
Silver Sponsors
ChemAxon
Silver Sponsor
Trusted by over one million active users, Chemaxon is renowned for industry-leading software supporting scientific discovery with calculation, search and drawing tools. Our applications are widely used in life sciences R&D and education. We work with a variety of industries, counting most major pharmaceutical companies among our clients. Our offices are located in Budapest, Basel, Boston and San Diego, with distributors around the world.
XtalPi
Silver Sponsor
XtalPi is a global technology platform company powered by artificial intelligence (AI) and robotics. Founded in 2015, XtalPi is dedicated to driving intelligent and digital transformation in life sciences and discovering better therapeutics and new materials. By integrating and synergizing quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of innovative solutions, services, and products to empower our partners in the biopharmaceutical, chemical, new energy, and new materials sectors worldwide.
Bronze Sponsors
Network & Programme Sponsors
Concept Life Sciences
Network & Programme Sponsor
Concept Life Sciences, a collaborative client-centred approach. We are a multi-disciplined Contract Research Organisation based in the UK providing market-leading scientific services globally. Over the past 25 years, Concept Life Sciences and its heritage companies have played a pivotal role in guiding numerous clients along their path to clinical success and many of these clients have evolved into enduring scientific collaborators. Within a decade, the collaborative efforts of experts from our heritage businesses — Peakdale Molecular, CXR Biosciences, and Aquila Biomedical — have propelled us beyond the cumulative impact of our individual components, fostering substantial growth and advancement. We are based across 4 research sites in the UK delivering discovery research, as well as GMP, GLP, and GCP-regulated work. Whether it is delivering whole programs of research, or bespoke studies, we deliever a a collaborative client-centred approach. Our services include discovery chemistry, specialist translational biology for immunology, oncology and neuroscience, biologics, biophysical assays services, ADMET & DMPK, bioanalysis, toxicology, histology, analytical services, including materials characterisation and physiochemical analysis, process research and development, and GMP manufacturing.
The Role of Immuno-Organoids in Drug Discovery And Disease Modelling
A study conducted by Roche demonstrates how to create new human models with tissue-integrated immune cells.
Strategic Acquisition: Otsuka Pharmaceutical to Pay Up to $1.1 billion to Acquire Jnana Therapeutics' Drug Discovery Platform
The Japanese healthcare company Otsuka Pharmaceutical will acquire clinical-stage biotech Jnana Therapeutics.
Exscientia and Amazon Web Services Join Forces to Maximise the Potential Of Generative AI in Drug Discovery
Exscientia, a biotech and pioneer in technology-driven drug design, has teamed up with Amazon Web Services to bolster its AI drug discovery platform.
.jpg)
Building Partnerships & Fostering An Inter-Disciplinary Approach In The Fight Against Anti-Microbial Resistance
This article outlines two examples of partnerships that aim to tackle the global issue of anti-microbial resistance. This overlooked yet prominent threat continues to pose challenges for scientists, policymakers, and governments.
Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Boston Marriott Cambridge
50 Broadway, Cambridge, MA 02142, United States
Public Transportation:
The nearest Bus station is South Station.
The nearest Subway station is Kendall/MIT.
The nearest Train stations are North Station and South Station.
For more information, please click here.
By Air:
Boston Logan International Airport is the nearest airport to the venue – 5 miles from the property.
For more information, please call +1 800-2356426 or click here.
Parking:
On site valet parking: $58.99 (valet with in/out privileges)
Off site self-parking: $48.00 daily (no in/out privileges)
Information regarding accommodation for this event will be added soon
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Discovery US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
